Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis

NCT00287573 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Restenosis

Interventions

DEVICE: TAXUS Express2
PROCEDURE: Brachytherapy (beta source)

Sponsor

Boston Scientific Corporation